*Some Market data delayed by 15 mins.

Avalo Therapeutics, Inc. Common Stock

Symbol: AVTX (NASDAQ)
0.00 ▼ (-100.00%) -11.100

Company Description:
Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

Key Stats
  • Today's Open: $0
  • Today's High: $0
  • Today's Low: $0
  • Today's Volume: 0
  • Yesterday Close: $11.1
  • Yesterday High: $11.48
  • Yesterday Low: $9.315
  • Yesterday Volume: 59.53K
  • Last Min Volume: 0
  • Last Min High: $0
  • Last Min Low: $0
  • Last Min VWAP: $0
Company Profile
  • Name: Avalo Therapeutics, Inc. Common Stock
  • Website: https://www.avalotx.com
  • Listed Date: 2015-11-13
  • Location: ROCKVILLE, MD
  • Market Status: Active
  • CIK Number: 0001534120
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $11.48M
  • Round Lot: 100
  • Outstanding Shares: 1.03M
  • Asset Type: CS
RECENT FILINGS FOR AVTX
Filing DateFiling TypeFormat
2024-05-13SC 13GView
2024-05-1310-QView
2024-05-138-KView
2024-04-23SC 13GView
2024-04-09DView
2024-04-05SC 13GView
2024-04-033View
2024-04-033View
2024-04-033View
2024-03-2910-KView
2024-03-298-KView
2024-03-28DEFA14AView
2024-03-288-KView
2024-02-14SC 13G/AView
2024-02-14SC 13G/AView
2024-02-14SC 13G/AView
2024-02-14SC 13G/AView
2024-01-318-KView
2023-12-288-KView
2023-12-214View
Latest News

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.